Literature DB >> 14678270

NK cells modulate the cytotoxic activity generated by Mycobacterium leprae-hsp65 in leprosy patients: role of IL-18 and IL-13.

S de la Barrera1, M Finiasz, S Fink, J Ilarregui, M Aleman, L Olivares, M C Franco, G Pizzariello, M del Carmen Sasiain.   

Abstract

Protection against intracellular pathogens such as Mycobacterium leprae is critically dependent on the function of NK cells at early stages of the immune response and on Th1 cells at later stages. In the present report we evaluated the role of IL-18 and IL-13, two cytokines that can influence NK cell activity, in the generation of M. leprae-derived hsp65-cytotoxic T lymphocytes (CTL) from peripheral blood mononuclear cells (PBMC) of leprosy patients. We demonstrated that IL-18 modulates hsp65-induced CTL generation and collaborates with IL-12 for this effect. In paucibacillary (PB) patients and normal controls (N) depletion of NK cells reduces the cytolytic activity. Under these conditions, IL-12 cannot up-regulate this CTL generation, while, in contrast, IL-18 increases the cytotoxic activity both in the presence or absence of NK cells. IL-13 down-regulates the hsp65-induced CTL generation and counteracts the positive effect of IL-18. The negative effect of IL-13 is observed in the early stages of the response, suggesting that this cytokine affects IFNgamma production by NK cells. mRNA coding for IFNgamma is induced by IL-18 and reduced in the presence of IL-13, when PBMC from N or PB patients are stimulated with hsp65. Neutralization of IL-13 in PBMC from multibacillary (MB) leprosy patients induces the production of IFNgamma protein by lymphocytes. A modulatory role on the generation of hsp65 induced CTL is demonstrated for IL-18 and IL-13 and this effect takes place through the production of IFNgamma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14678270      PMCID: PMC1808925          DOI: 10.1111/j.1365-2249.2004.02334.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  41 in total

1.  IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response.

Authors:  T Hoshino; R H Wiltrout; H A Young
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  Anti-inflammatory actions of interleukin-13: suppression of tumor necrosis factor-alpha and antigen-induced leukocyte accumulation in the guinea pig lung.

Authors:  M L Watson; A M White; E M Campbell; A W Smith; J Uddin; T Yoshimura; J Westwick
Journal:  Am J Respir Cell Mol Biol       Date:  1999-05       Impact factor: 6.914

3.  IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection.

Authors:  V E García; K Uyemura; P A Sieling; M T Ochoa; C T Morita; H Okamura; M Kurimoto; T H Rea; R L Modlin
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

4.  IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.

Authors:  T Yoshimoto; K Takeda; T Tanaka; K Ohkusu; S Kashiwamura; H Okamura; S Akira; K Nakanishi
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

Review 5.  Regulation of interferon-gamma production by IL-12 and IL-18.

Authors:  H Okamura; S Kashiwamura; H Tsutsui; T Yoshimoto; K Nakanishi
Journal:  Curr Opin Immunol       Date:  1998-06       Impact factor: 7.486

6.  IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor.

Authors:  Y Hyodo; K Matsui; N Hayashi; H Tsutsui; S Kashiwamura; H Yamauchi; K Hiroishi; K Takeda; Y Tagawa; Y Iwakura; N Kayagaki; M Kurimoto; H Okamura; T Hada; H Yagita; S Akira; K Nakanishi; K Higashino
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

7.  Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD.

Authors:  M C Sasiain; S de la Barrera; S Fink; M Finiasz; M Alemán; M H Fariña; G Pizzariello; R Valdez
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

8.  Interleukin-13 down-regulates the expression of neutrophil-derived macrophage inflammatory protein-1 alpha.

Authors:  T M Ohta; T Kasama; M Hanyuuda; Y Hatano; K Kobayashi; M Negishi; H Ide; M Adachi
Journal:  Inflamm Res       Date:  1998-09       Impact factor: 4.575

9.  Differentiation of human NK cells into NK1 and NK2 subsets.

Authors:  D Peritt; S Robertson; G Gri; L Showe; M Aste-Amezaga; G Trinchieri
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

10.  Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4.

Authors:  C R Yu; R A Kirken; M G Malabarba; H A Young; J R Ortaldo
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422

View more
  2 in total

1.  IL-9 promotes anti-Mycobacterium leprae cytotoxicity: involvement of IFNgamma.

Authors:  M R Finiasz; M C Franco; S de la Barrera; L Rutitzky; G Pizzariello; M del Carmen Sasiain; J-C Renauld; J Van Snick; S Fink
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

2.  Immune Checkpoints in Leprosy: Immunotherapy As a Feasible Approach to Control Disease Progression.

Authors:  Hayana Ramos Lima; Thaís Helena Gasparoto; Tatiana Salles de Souza Malaspina; Vinícius Rizzo Marques; Marina Jurado Vicente; Elaine Camarinha Marcos; Fabiana Corvolo Souza; Maria Renata Sales Nogueira; Jaison Antônio Barreto; Gustavo Pompermaier Garlet; João Santana da Silva; Vânia Nieto Brito-de-Souza; Ana Paula Campanelli
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.